Procurement
Expert Panel
Create New Account
Login
logo
Report store
Insights
Survey
Consulting
Book discovery call
logo

Epigenetics Market: Current Analysis and Forecast (2021-2027)

Region:Global

Product Code:UMHE21331

Download Sample Report
Published On

July 2021

Total pages

162

About the Report

Epigenetics is stream of genetics that involves the study of how the cells control gene activity without altering the sequence of DNA i.e., these modifications bring out only phenotypic changes in an organism rather than genotypic change. Epigenetic changes are basically the modifications in DNA that regulate whether genes are turned on or off. these alterations are dynamic and are stable enough to pass from one generation to another.

With rapid technological advancement and rising investment in research & development of pharmaceutical & biotechnology companies, the epigenetics market is witnessing an uptick all over the globe. For instance, The Pharmaceutical Research and Manufacturers of America (PhRMA) trade group represents the leading biopharmaceutical research companies in the United States. In 2019, the research and development (R&D) expenditure of its member companies reached USD 83 billion worldwide, up from USD 79.6 billion in 2018. Furthermore, the growing focus on epigenetics research owing to its wide scope of applications in non-oncology diseases, personalized medicine, and targeted therapy, among other varied segments is propelling the growth of this market.

The epigenetics market is growing exponentially on account of growth in mortality rates and incidences of cancer and other chronic diseases coupled with the heavy demand for medicines across the world. For instance, according to the World Health Organization, cancer is one of the leading causes of death globally, accounting for nearly 9.6 million deaths in 2018. this number has been increased and has reached around 10 million deaths globally in 2020. Therefore, scientists across the world are carrying out high-level research on cancer therapeutics and diagnostics including research on epigenetics biomarkers as many recent studies suggest that epigenetics changes correlate with cancer development.

Based on product, the market is fragmented into enzymes, instruments, kits, reagents, and others. The kits segment generated revenue of USD XX million in 2020 and is expected to grow at a CAGR of XX% during the forecast period to reach a market valuation of USD XX million by 2027F owing to the growing adoption of epigenetics procedures and increase in launch of new and advanced epigenetics kits.

Based on the application, the market is fragmented into oncology, metabolic diseases, immunology, developmental biology, cardiovascular diseases, and others. The oncology segment dominated the market and generated revenue of USD XX million in 2020 and maintain its dominance owing to the growing use of epigenetics in cancer research.

The Epigenetics research and development and utilization are available at various centers including pharmaceutical & biotechnology companies, academic & research institutes, contract research organization, and others. The pharmaceutical & biotechnology companies se segment is anticipated to dominate the market during the analyzed period and reach USD XX million by 2027F owing to the growing number of these companies and investments in R&D.

For a better understanding of the market adoption of the Epigenetics market, the market is analyzed based on its worldwide presence in the countries such as North America (United States and Canada), Europe (Germany, France, Italy, Spain, United Kingdom and Rest of Europe), Asia-Pacific (China, Japan, India, Australia, and Rest of APAC), and Rest of World. North America constitutes a major market for the epigenetics industry and generated revenue of USD XX million in 2020 owing to the increasing incidence of cancer and other diseases, rising healthcare spending, and increasing government initiatives in the region.

Some of the major players operating in the market include Illumina, Thermo Fisher Scientific, QIAGEN, Agilent Technologies, Bio-Rad Laboratories, PerkinElmer, Merck & co, Abcam PLC, Active Motif, Diagenode, etc. Several M&A's along with partnerships have been undertaken by these players to develop new and advanced technologies.

Scope of the Report

Products

Epigenetics is stream of genetics that involves the study of how the cells control gene activity without altering the sequence of DNA i.

Companies

Illumina, Thermo Fisher Scientific, QIAGEN, Agilent Technologies, Bio-Rad Laboratories, PerkinElmer, Merck & co, Abcam PLC, Active Motif, and Diagenode are some of the prominent players operating in the global epigenetics market. Several M&A's along with partnerships have been undertaken by these players to develop new and advanced epigenetics products.

Table of Contents

1 MARKET INTRODUCTION

1.1 Market Definitions

1.2 Objective of the Study

1.3 Limitation

1.4 Stake Holders

1.5 Currency Used in Report

1.6 Scope of the Global Epigenetics Market Study

2 RESEARCH METHODOLOGY OR ASSUMPTION

2.1 Research Methodology for the Global Epigenetics Market

2.1.1 Main Objective of the Global Epigenetics Market

3 MARKET SYNOPSIS

4 EXECUTIVE SUMMARY

5 COVID-19 IMPACT

6 GLOBAL EPIGENETICS MARKET REVENUE

7 MARKET INSIGHTS BY PRODUCT

7.1 Enzymes

7.1.1 DNA-modifying enzymes

7.1.2 Protein-modifying enzymes

7.1.3 RNA-modifying enzymes

7.2 Instruments

7.2.1 Nex-generation sequencers

7.2.2 qPCRs

7.2.3 Mass spectrometers

7.2.4 Sonicators

7.2.5 Others

7.3 Kits

7.3.1 ChIP-sequencing kits

7.3.2 RNA sequencing kits

7.3.3 Bisulfite conversion kits

7.3.4 Whole genome amplification kits

7.3.5 5-hmC & %-mC analysis kits

7.3.6 Others

7.4 Reagents

7.4.1 Antibodies

7.4.2 Buffers

7.4.3 Histones

7.4.4 Magnetic beads

7.4.5 Primers

7.4.6 Others

7.5 Others

8 MARKET INSIGHTS BY APPLICATION

8.1 Oncology

8.2 Metabolic diseases

8.3 Immunology

8.4 Developmental biology

8.5 Cardiovascular diseases

8.6 Others

9 MARKET INSIGHTS BY END-USERS

9.1 Pharmaceutical & Biotechnology Companies

9.2 Academic & Research Institutes

9.3 Contract Research Organizations

9.4 Others

10 MARKET INSIGHTS BY REGION

10.1 NORTH AMERICA EPIGENETICS MARKET

10.1.1 United States

10.1.2 Canada

10.1.3 Rest of North America

10.2 EUROPE EPIGENETICS MARKET

10.2.1 Germany

10.2.2 France

10.2.3 United Kingdom

10.2.4 Spain

10.2.5 Italy

10.2.6 Rest of Europe

10.3 ASIA PACIFIC EPIGENETICS MARKET

10.3.1 China

10.3.2 Japan

10.3.3 India

10.3.4 Australia

10.3.5 Rest of Asia Pacific

10.4 REST OF THE WORLD EPIGENETICS MARKET

11 EPIGENETICS MARKET DYNAMICS

11.1 Market Drivers

11.2 Market Challenges

11.3 Impact Analysis

12 EPIGENETICS MARKET OPPORTUNITIES

13 EPIGENETICS MARKET TRENDS & INSIGHTS

14 LEGAL & REGULATORY FRAMEWORK

15 DEMAND AND SUPPLY SIDE ANALYSIS

15.1 Demand Side Analysis

15.2 Supply Side Analysis

15.2.1 Top Product Launches

15.2.2 Top Business Partnerships

15.2.3 Top Merger & Acquisitions

16 VALUE CHAIN ANALYSIS

17 COMPETITIVE SCENARIO

17.1 Porter's Five forces analysis

17.1.1 Bargaining power of Supplier

17.1.2 Bargaining power of Buyer

17.1.3 Industry Rivalry

17.1.4 Availability of Substitute

17.1.5 Threat of new Entrants

18 COMPANY PROFILED

18.1 Agilent Technologies

18.1.1 Key Facts

18.1.2 Business Description

18.1.3 Key Product/Services Offerings

18.1.4 Growth Strategy

18.1.5 SWOT Analysis

18.1.6 Key Financials

18.1.6.1 Revenue Split

18.1.6.2 Financial Overview of Agilent Technologies

18.1.7 Recent Developments

18.1.7.1 Product Launch

18.1.7.2 Partnerships

18.1.7.3 Business Expansion and Investments

18.1.7.4 Merger and Acquisition

18.2 Thermo Fisher Scientific

18.3 Illumina Inc

18.4 Merck & co

18.5 Abcam PLC

18.6 Active Motif

18.7 Bio-Rad

18.8 QIAGEN

18.9 Diagenode

18.10 PerkinElmer

19 DISCLAIMER

Research Methodology

Why Buy From Us?

RRR
Refine Robust Result (RRR) Framework

What makes us stand out is that our consultants follows Robust, Refine and Result (RRR) methodology. i.e. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents facts and opinions and Result for presenting data with story

reach
Our Reach Is Unmatched

We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.

Research
Shifting the Research Paradigm

While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.

Insite
More Insights-Better Decisions

With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.

Trust
Transparency and Trust

Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.

support
Round the Clock Support

If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.

Why Client Choose Us?

400000+ Reports in repository
150+ Consulting project a year
100+ Analysts
8000+ Client Queries in 2022